Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Secondary diabetes].

Ugeskrift for laeger·2026
Same author

Pre-Exercise Galactose or Lactose Reduces Glycaemic Excursions During Exercise in Adults With Type 1 Diabetes: A Randomised, Double-Blind, Crossover Trial.

Diabetes, obesity & metabolism·2026
Same author

Milk Fat Globule Membrane in a Novel High-Fat Spread Does Not Acutely Affect Postprandial Lipidemia in Healthy Individuals-A Randomized, Double-Blind Crossover Trial.

The Journal of nutrition·2026
Same author

Genetic Insights Into AVP Deficiency: Identification of a Novel AVP Variant and Compilation of a Curated Catalogue of Pathogenic Variants.

Clinical genetics·2026
Same author

Cardiometabolic effects of time-restricted eating.

American journal of physiology. Cell physiology·2026
Same author

Not racemic after all: stereochemical composition of a commercially available sodium lactate solution.

Critical care (London, England)·2026

Related Experiment Video

Updated: Jul 4, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

[Glucocorticoid-induced diabetes].

Rasmus Fuglsang-Nielsen1, Katrine Bagge Hansen2, Mads Bisgaard Bengtsen3,4

  • 1Medicinsk Afdeling, Regionshospitalet Horsens.

Ugeskrift for Laeger
|July 3, 2026
PubMed
Summary
This summary is machine-generated.

Glucocorticoid-induced diabetes (GID) presents unique hyperglycemia patterns, often in the afternoon. Early detection and intervention are crucial for managing this serious side effect and preventing severe complications.

Related Experiment Videos

Last Updated: Jul 4, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Glucocorticoid-induced diabetes (GID) is a common adverse effect of glucocorticoid therapy.
  • GID is characterized by a distinct glucose metabolism profile, including afternoon/evening postprandial hyperglycemia.
  • Fasting blood glucose levels may appear normal, complicating diagnosis.

Purpose of the Study:

  • To review the distinct characteristics of GID.
  • To emphasize the need for tailored management strategies for GID.
  • To highlight the importance of early intervention in mitigating severe health risks associated with GID.

Main Methods:

  • This review synthesizes current literature on glucocorticoid-induced diabetes.
  • It focuses on the diagnostic challenges and management principles.
  • The review examines the link between GID and adverse health outcomes.

Main Results:

  • GID requires specific management distinct from other forms of diabetes.
  • Proactive risk stratification and targeted screening are essential for early GID detection.
  • Timely intervention can reduce the risk of serious complications.

Conclusions:

  • Effective management of GID is critical for patient outcomes.
  • Addressing the unique glycemic profile of GID is paramount.
  • Early and tailored interventions can prevent severe complications such as increased mortality, cardiovascular events, and infections.